Showing results (31-40 of 299) with videos related to

Sort By:
Pageof 30
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2009
Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancerYelena Krupitskaya, Heather A Wakelee
Cancer Treatment and Research Communications|May 16, 2020
A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORSJonathan W Riess, Nadine S Jahchan, Millie Das, et al.
Clinical Lung Cancer|November 28, 2021
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung CancerJessica A Hellyer, Maya N White, Rebecca M Gardner, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 17, 2009
Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapyJerry Y Hsu, Heather A Wakelee
Clinical Lung Cancer|September 15, 2005
Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitorsHeather A Wakelee, Branimir I Sikic
Cancer|May 8, 2024
Top advances of the year: Perioperative therapy for lung cancerJacqueline V Aredo, Heather A Wakelee
Thoracic Surgery Clinics|April 25, 2020
Adjuvant ChemotherapyJessica A Hellyer, Heather A Wakelee
Pageof 30